Every SEC Form 3/4/5 on record for this filer (CIK 1232505) — 6 issuers, 63 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CB | Chubb Ltd | Director | 2020-05-21 → 2026-05-26 | 8 | — |
| BHVN | Biohaven Ltd. | Director | 2020-06-12 → 2026-04-30 | 15 | — |
| AGN | Allergan plc | Director · lapsed | 2019-02-20 → 2020-05-11 | 5 | — |
| CELG | CELGENE CORP /DE/ | see remarks · Director · lapsed | 2015-07-29 → 2018-01-31 | 23 | −$54M |
| MDCO | MEDICINES CO /DE | Director · lapsed | 2016-02-19 → 2017-11-13 | 5 | — |
| DHR | DANAHER CORP /DE/ | Director · lapsed | 2016-07-15 → 2017-05-17 | 5 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
3 of 6 issuers are covered and open a security page; the rest are on file here only.